211 related articles for article (PubMed ID: 16909314)
1. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas.
Fallon S; Shearman E; Sershen H; Lajtha A
Neurochem Res; 2007; 32(4-5):535-53. PubMed ID: 16909314
[TBL] [Abstract][Full Text] [Related]
2. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
[TBL] [Abstract][Full Text] [Related]
3. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes.
Rossi S; Singer S; Shearman E; Sershen H; Lajtha A
Neurochem Res; 2005 Apr; 30(4):541-58. PubMed ID: 16076024
[TBL] [Abstract][Full Text] [Related]
4. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.
Singer S; Rossi S; Verzosa S; Hashim A; Lonow R; Cooper T; Sershen H; Lajtha A
Neurochem Res; 2004 Sep; 29(9):1779-92. PubMed ID: 15453274
[TBL] [Abstract][Full Text] [Related]
5. Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function.
Shearman E; Rossi S; Sershen H; Hashim A; Lajtha A
Neurochem Res; 2005 Aug; 30(8):1055-66. PubMed ID: 16258855
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-induced monoamine neurotransmitter changes in the brain of young rats.
Shearman E; Fallon S; Sershen H; Lajtha A
Brain Res Bull; 2008 Aug; 76(6):626-39. PubMed ID: 18598854
[TBL] [Abstract][Full Text] [Related]
7. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
8. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
Harte M; O'Connor WT
Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
[TBL] [Abstract][Full Text] [Related]
10. Food reward-induced neurotransmitter changes in cognitive brain regions.
Fallon S; Shearman E; Sershen H; Lajtha A
Neurochem Res; 2007 Oct; 32(10):1772-82. PubMed ID: 17721820
[TBL] [Abstract][Full Text] [Related]
11. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
Fu Y; Matta SG; Gao W; Brower VG; Sharp BM
J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219
[TBL] [Abstract][Full Text] [Related]
12. Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in vivo at low doses.
Rossi S; Singer S; Shearman E; Sershen H; Lajtha A
Neurochem Res; 2005 Jan; 30(1):91-103. PubMed ID: 15756937
[TBL] [Abstract][Full Text] [Related]
13. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.
Allers KA; Dremencov E; Ceci A; Flik G; Ferger B; Cremers TI; Ittrich C; Sommer B
J Sex Med; 2010 May; 7(5):1757-67. PubMed ID: 20163532
[TBL] [Abstract][Full Text] [Related]
14. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
Harrison AA; Gasparini F; Markou A
Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
[TBL] [Abstract][Full Text] [Related]
16. Disinhibition of spinal responses to primary afferent input by antagonism at GABA receptors in urethane-anaesthetised rats is dependent on NMDA and metabotropic glutamate receptors.
Buesa I; Ortiz V; Aguilera L; Torre F; Zimmermann M; Azkue JJ
Neuropharmacology; 2006 Apr; 50(5):585-94. PubMed ID: 16412481
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: a microdialysis study.
Hu XJ; Wang FH; Stenfors C; Ogren SO; Kehr J
Eur Neuropsychopharmacol; 2007 Sep; 17(9):580-6. PubMed ID: 17234388
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat.
Harte M; O'Connor WT
Neuroscience; 2005; 130(1):215-22. PubMed ID: 15561437
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
